HomeEXPRS2 • STO
add
ExpreS2ion Biotech Holding AB
Previous close
kr 25.00
Day range
kr 24.80 - kr 27.40
Year range
kr 17.84 - kr 143.80
Market cap
71.24M SEK
Avg Volume
16.42K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 1.69M | -9.00% |
Operating expense | 13.62M | -41.38% |
Net income | -10.46M | 52.08% |
Net profit margin | -619.30 | 47.34% |
Earnings per share | — | — |
EBITDA | -12.72M | 41.47% |
Effective tax rate | 19.60% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 76.40M | — |
Total assets | 104.52M | — |
Total liabilities | 35.17M | — |
Total equity | 69.34M | — |
Shares outstanding | 2.10M | — |
Price to book | 0.76 | — |
Return on assets | -33.06% | — |
Return on capital | -51.09% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -10.46M | 52.08% |
Cash from operations | -16.73M | -36.28% |
Cash from investing | 34.00K | 236.00% |
Cash from financing | 25.17M | 854.28% |
Net change in cash | 7.86M | 170.65% |
Free cash flow | -14.71M | — |
About
Founded
2015
Website
Employees
18
